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The efﬁciency of the ligand-building module of ARP/wARP
version 6.1 has been assessed through extensive tests on a
large variety of protein–ligand complexes from the PDB, as
available from the Uppsala Electron Density Server. Ligand
building in ARP/wARP involves two main steps: automatic
identiﬁcation of the location of the ligand and the actual
construction of its atomic model. The ﬁrst step is most
successful for large ligands. The second step, ligand construc-
tion, is more powerful with X-ray data at high resolution and
ligands of small to medium size. Both steps are successful for
ligands with low to moderate atomic displacement parameters.
The results highlight the strengths and weaknesses of both the
method of ligand building and the large-scale validation
procedure and help to identify means of further improvement.
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1. Introduction
A key to understanding the function of proteins in their
biological context is the modelling and the interpretation of
their interactions with small molecules, commonly known as
ligands. Several thousand such compounds are known today.
Many currently available protein–ligand structures represent
the complex of a protein (drug target) with a potential or, less
often, an available life-saving drug (Schindler et al., 2000).
During lead optimization in the process of structure-assisted
drug development, numerous structures need to be deter-
mined which essentially represent the same protein com-
plexed with a variety of ligand molecules under different
soaking conditions. Although computational modelling and
docking studies of large in silico libraries play a predominant
role in this stage, X-ray crystallography is used as the primary
experimental technique to determine protein–ligand complex
structures in order to provide detailed structural information.
Development of methods for automatic building of mole-
cular models in X-ray crystallography has so far been focused
almost exclusively on the construction of the protein model
alone, which was (and often still is) the most labour-intensive
and time-consuming step. Less emphasis has been given to the
completion of a macromolecular model, which often includes
addition and reﬁnement of bound ligand molecules. Particu-
larly in the course of a series of ligand studies, the main goal of
automation is to add ligands to an otherwise existing and well
reﬁned protein structure. During the last few years, a number
of methods have started to emerge that address this topic.
There have been advances in bioinformatics for the prediction
of a possible ligand and inferring the protein function given a
known binding site and its shape (e.g. Morris et al., 2005).
Crystallographic approaches for building and ﬁtting a ligand
of known chemistry to a known or even an unknown locationin the electron density include BLOB (Diller et al., 1999),
which uses a Monte Carlo technique to position a ligand into
an electron-density map in an appropriate conformation,
X-Ligand (Oldﬁeld, 2001) and Coot (Emsley & Cowtan,
2004), which match random conformations of the ligand to the
shape of the density cluster through a principal component
analysis, a technique utilizing a medial axis transform of an
electron-density isosurface (Aishima et al., 2005), SOLVE/
RESOLVE (Terwilliger et al., 2006), which breaks the ligand
into rigid fragments and then links them subject to the density
and stereochemical constraints, and ARP/wARP (Zwart et al.,
2004), which we deal with in this paper in detail.
Like all methods outlined above, the ligand-building
module in ARP/wARP attempts to ﬁt a complete ligand
molecule into electron density. Its main difference from other
approaches lies in the construction of a ligand through an
iterative atom-by-atom expansion. This may potentially allow
the construction of partially occupied ligands and let the
researcher know which part of the ligand has tight binding and
where to. In order to proceed in this direction, it is essential to
extensively analyse the efﬁciency of the ligand-building
module in ARP/wARP and to pinpoint its current achieve-
ments and limitations. Therefore, as a performance
benchmark we attempted the reconstruction of known
protein–ligand complexes.
2. Methods
The ﬁrst step of a study that aims at assessing the performance
of any automated process is the selection of the test set. To
construct the test set here, we chose PDB entries from the
Electron Density Server (EDS) in Uppsala (Kleywegt et al.,
2004) which contained at least one bound ligand. As implied
by the use of the EDS, all these entries have readily available
validated associated X-ray diffraction data sets. For conve-
nience in the downstream selection of the test set, these
entries were organized in a relational database. The next steps
involved automating the execution of the ARP/wARP ligand-
building procedure over the whole test set and evaluating
success or failure on the ﬂy. For each case, this included
feeding the program with adequately formatted input (the
coordinates of the protein, the diffraction data and a feasible
conformer of the relevant ligand with correct stereochemical
parameters) and delivering output for post-run analysis. The
correctness of the reconstruction was then assessed by
comparison of the automatically reconstructed ligand to the
original ligand coordinates present in the PDB entry. Finally,
an overall analysis was performed to derive indications of
software performance and directions for further improve-
ments.
It is obvious that in such an evaluation the ﬁnal ﬁgures
depend on each of the preceding steps, i.e. on the software
itself, on the selected test sample and on the success indicator
chosen to judge correct reconstruction. All the numbers
obtained in this study are thus relative to the conditions in
which the test was conducted. To be of practical interest, the
conditions were set close to those of the ‘standard’ black-box
use of ARP/wARP.
2.1. Algorithm for ligand building
The ligand-building module of ARP/wARP version 6.1
(released in July 2004) aims at positioning a bound ligand of
known chemistry in a difference electron-density map. The
main steps of the algorithm (Zwart et al., 2004) are brieﬂy
outlined below.
(i) The protein model without the ligands and solvent is
reﬁned with the CCP4 version of REFMAC5 (Murshudov et
al., 1997; Collaborative Computational Project, Number 4,
1994) against the diffraction data. Manual intervention or
automatic means of drastically modifying the protein model
are not carried out. The resulting structure factors are used to
construct a  A-weighted difference density map (mFo   DFc,
 c), into which the ligand should be ﬁtted.
(ii) The largest cluster in the difference electron-density
map is selected and parameterized using a sparse-grid repre-
sentation.
(iii) A number of possible ligand models are constructed by
iterative assignment of ligand-atom labels to cluster grid
nodes.
(iv) All constructed models of the ligand are reﬁned in real
space and scores are derived to select the single best model.
A crucial step in this procedure is the volume-based selec-
tion of the largest density cluster (step ii). The expected ligand
volume is computed from the volume of the ligand multiplied
by an excess volume factor whose numerical value can either
be the empirical default provided (1.3) or can be adjusted by
the user. In the difference density map, a contouring density
level  thres is deﬁned such that the volume of the largest cluster
equals the expected ligand volume. Finding a value of  thres
that satisﬁes this criterion is a simple root-ﬁnding problem
solved by bracketing and bisection (see, for example, Arfken,
1985). The procedure is thus designed for cases where the
ligand to be built is the largest of possibly several ligands
bound to the protein. Otherwise, the construction of the ligand
may be attempted at a wrong location. Consequently, if there
are several ligands present, they can be built one after
another, starting with the largest ligand and working through
to the smallest. In the current evaluation study, we excluded
this consecutive ligand building for the sake of simplicity. This
therefore self-deﬁnes a strong criterion for discrimination of a
priori ‘easy cases’, where a large ligand dominates the differ-
ence density map, from ‘hard cases’ where the signature of a
small ligand may be lost in the presence of larger ligands and
even possibly solvent or noise.
The ligand construction stricto sensu (step iii) consists of
putting ligand atom labels on the selected density cluster grid
nodes (‘label swap’). As described in Zwart et al. (2004), on
the basis of the stereochemistry of the search model the
method deﬁnes the order in which atoms are added to a partial
ligand model that is iteratively completed. This completion is
constrained by the ligand topology and the score for each
model takes into account density, bond and angle-bonded
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The optimization strategy for ﬁnding suitable models is a
quasi-exhaustive graph search attempting to match the ligand
topology to the grid nodes of the density cluster. The fact that
the volume of the cluster is set to be somewhat larger than the
true volume of the ligand is essential for the construction of
many (rather than one) putative models. The amount of search
possibilities is deﬁned by a ‘branch-and-bound’ approach. The
intrinsic computational complexity of the ligand construction
is mainly dependent on the ligand size and on the resolution of
the data. Indeed, the complexity of mapping N ligand atoms
on M cluster grid nodes increases drastically with an increase
in the ligand size. At the same time, low-resolution data and
high atomic displacement parameters (ADPs) of the ligand
yield a smoothed density cluster where the power of the
‘density score’ is decreased and the construction of a higher
number of putative models becomes necessary.
The ﬁnal selection of the single ‘best’ ligand model is carried
out at step (iv), when all putative models are subject to
stereochemically restrained real-space reﬁnement in the
difference electron density. The selected model is that with the
lowest goodness-of-ﬁt value.
2.2. Defining the test sample
All EDS entries that contain at least one ligand were
organized in a simple SQL database with one table for the
protein models that included the PDB code, the resolution of
the diffraction data, ligand names, occupancy and ADPs of the
ligands as well as their real-space R factors. This table was
linked to a second SQL table containing the list of unique
ligands with distinct types, their size and topology. Entries
suitable for the test sample have been selected by executing
database queries with an application of the desired criteria on
the ﬂy.
The large-scale test exempliﬁed the need for thorough pre-
processing of the PDB entries. The selected subset of the EDS
entries still contained a variety of format errors and incon-
sistencies. We carried out an additional cleanup and repair of
the entries where format-conﬂicting features could be identi-
ﬁed. In addition, the following cases were discarded from the
list of building tasks: (i) non-protein cases (DNA or RNA
fragments or multi-ligand conglomerates), (ii) cases with DNA
or RNA as heterocompounds, (iii) heterocompounds that are
part of the protein main chain, (iv) partially built and multi-
meric ligands and (v) ligands consisting of less than ﬁve non-H
atoms.
The ﬁnally selected test sample consisted of 3884 PDB
entries encompassing 1447 unique ligands. From these entries,
6132 ligand-building tasks have been constructed. The number
of ligand-building tasks per protein can be larger than one; it is
deﬁned by the number of suitable ligand types present, irre-
spective of the number of their copies.
The ARP/wARP version 6.1 ligand-building module (Zwart
et al., 2004) has been designed to construct the single largest
and fully occupied ligand. Of the selected 6132 tasks, 3369
fulﬁl the above constraint and hereafter the overall results are
presented based on these tasks, with a single exception
described in x3.7. We distinguish between 706 small ligands
(ﬁve or six non-H atoms) and 2663 large ligands.
The test sample is very diverse in terms of the ligand size
(Fig. 1), with the largest ligand, adeninylpentylcobalamin in
PDB entry 1eex, containing 106 non-H atoms. Ligands with
ﬁve or six atoms (e.g. sulfate and phosphate ions) largely
outnumber other ligands and this was taken into account to
avoid bias in the analysis.
2.3. Automating the runs
Shell scripts were set up to download the diffraction data (in
MTZ format), the PDB ﬁles from the EDS and the ligand
templates from the Hetero-compound Information Centre in
Uppsala (HIC-Up; Kleywegt & Jones, 1998) as well as to
automate the preparation and running of ligand-building
tasks. We used the ‘clean’ PDB ﬁles for each ligand, which
represent ideal coordinates that were prepared using the
CORINA program (Gasteiger et al., 1990) and are available
from the MSD (Golovin et al., 2005). All nonprotein atoms
were automatically removed from the PDB ﬁles and the ARP/
wARP ligand-building module was launched. In each building
task, the coordinates of the original ligand present in the PDB
ﬁle (hereafter called the reference ligand) were stored and
used for evaluation of the selected ligand site and comparison
with the reconstructed ligand. We note that the coordinates of
the reference ligands were assumed to be correct.
2.4. Assessment of the results
The automatic location of the ligand-binding site was
deemed successful if the reference ligand overlapped with the
selected density cluster.Overlap was considered to occur if the
shortest distance between any atom of the reference ligand
and any of the cluster grid points was smaller than 1.0 A ˚ . After
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Figure 1
Distribution of ligand sizes (non-H atoms) for the initially selected full
sample and the sample of largest ligands. Outstanding peaks reﬂect the
presence of widespread ligands, e.g. HED, ADP, ATP, HEM, NAP, FAD
for sizes 8, 27, 31, 43, 48 and 53, respectively.evaluation of the location, assessment of the ligand recon-
struction was carried out. This task proved nontrivial since
there is no single foolproof measure that indicates success or
failure. Ideally, a measure for the correctness of ligand
building should take into account both the conformation of
the built ligand and the validity of its intrinsic stereochemistry.
A simple line-by-line comparison of the PDB ﬁles for the
reference and built ligand (in other words, computation of the
distance for all pairs of atoms with identical atomic labels) is
too restrictive and may give false negatives (correct recon-
struction reported as being incorrect). For example, possible
equivalent conformations of aromatic rings related by a 180 
rotation around the C
 —C
  bond in tyrosine or phenylalanine
would be considered to be different models. Another measure,
the distance between each atom of one ligand and its nearest
neighbour in the counterpart, is too loose and often gives a
false positive. The metric that performs best in deﬁning a one-
to-one mapping is the distance between each atom in the built
ligand and its nearest neighbour in the reference ligand, with
the constraint that each atom in the latter can be selected only
once. The metric is not symmetrical and depends somewhat on
the order in which the atoms are taken. However, owing to its
inherent nonlinearity it is a robust ampliﬁer of discrepancies
between the models and thus acts as a very good quality
indicator. The root-mean-square deviation (r.m.s.d.) is subse-
quently computed as
r:m:s:d: ¼
1
N
P
i¼1;N
ðxref
i   xbuilt
i Þ
2
   1=2
;
where xref
i and xbuilt
i correspond to the coordinate vectors of
the ith atom of the reference and built ligand, respectively; N
is the number of ligand atoms.
The distribution of the r.m.s.d. values obtained from the
large-scale test exhibits three main regions (Fig. 2): (i) an
interatomic scale (below 1 A ˚ ), corresponding to correctly built
ligands, (ii) an intramolecular scale (between 1 and 10 A ˚ ),
where the ligand was built into the correct cluster but in a
wrong conformation, and (iii) the intermolecular scale (above
10 A ˚ ), where the ligand was built at an incorrect site. There-
fore, cases with r.m.s.d. values of equal or less than 1.0 A ˚ were
considered to be successful reconstructions. Such a coordinate
error should also be (almost) within the radius of convergence
of modern reﬁnement programs.
In cases where several identical ligands are present in the
PDB entry, the building process (both selection of the density
cluster and reconstruction of the ligand) is assessed regardless
of which copy of the particular ligand is ‘chosen’ by the soft-
ware. If, for example, a protein is complexed with three ATP
molecules, the reconstruction is declared successful if one of
them has been successfully built.
3. Results and discussion
3.1. Quality and quantity
The success of any ligand-building procedure strongly
depends on the quality of the density map of the ligand looked
for. A number of factors affecting this (resolution of the data,
ligand size and its ADPs) are discussed in the following
sections. Here, we address the point of how good the electron
density is overall. Clearly, for a ligand that is hardly bound at
all, an attempt to ﬁnd it would very much seem like Charles
Darwin’s blind man looking for a black cat in a dark room
when the cat is not actually there. As a measure of the overall
quality of the blob of the ligand density, we used a real-space
map correlation coefﬁcient (RSMCC) of the density calcu-
lated from the deposited reference ligand to the difference
electron-density map computed from the X-ray data. The
‘calculated’density was computed using the coordinates, ADP
and atomic types of the reference ligand. An additional
artiﬁcial exponential term was added to model series termi-
nations. RSMCC was computed on all density grid points that
were within 1.9 A ˚ distance of ligand atoms. Fig. 3 displays the
distribution of RSMCC for the total test set of single largest
and fully occupied ligand-building cases.
The values of RSMCC have a sharp peak at around 0.85–
0.95 corresponding to the structures where the ligand is well
deﬁned in the density. There is a long tail to the left, some
possible reasons for which are elaborated in the subsequent
sections. To give a visual impression on how RSMCC relates to
the map quality, Fig. 4 presents an example with the PDB
entries 1in7 and 1hw8, both reﬁned at a resolution of 2.0 A ˚
and containing a bound adenosinediphosphate molecule.
While the density for RSMCC of 93% is very clear, that for
RSMCC of 69% lacks experimental support and is difﬁcult to
interpret, particularly for the pyrophosphate part of the
ligand.
3.2. Overall results
In a small fraction of cases (5–6%) the ligand-building tasks
did not proceed to the end, largely owing to the remaining
inconsistencies in the PDB ﬁle or, sometimes, software
crashes. These cases are not taken into account in the subse-
quent statistical analysis.
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Figure 2
Distribution of r.m.s.d. values between the reconstructed and the
reference ligand. The plot highlights the three different regions: 1.0 A ˚
and below, correctly built ligand in correctly identiﬁed site; between 1.0 A ˚
and 10 A ˚ , the ligand is at a correct site but not properly built; above 10 A ˚ ,
the ligand is built at an incorrect location.An overall assessment of the performance of the procedure
along the pipeline of building steps is shown in Fig. 5. Large
ligands are built in 27% of cases and small ones in 31% of
cases.
For ‘good’ ligands, however, which we arbitrarily deﬁne as
those with a size of between ten and 40 non-H atoms and a
real-space map correlation coefﬁcient of above 80%, the
success rate approaches about half of the cases. The subset of
‘good’ ligands represents those which are well deﬁned in the
density.
We consider separately the performance of each of the two
main parts of the ligand-building procedure: the location of
the binding site and, given the correct binding site, the
construction of the ligand. The overall success rate mentioned
above clearly depends on the success of both these two steps.
The identiﬁcation of the ligand-binding site is evaluated on
the basis of 3321 entries (i.e. there were 48 inconsistencies
among the initial 3369 cases). The site has been successfully
identiﬁed in 64% of the total cases and for 82% for ‘good’
ligands. This indicates that consideration of the ligand-binding
site as a continuous blob of difference density and the
implemented method for choosing the appropriate density
threshold generally work well. The step of the actual
construction of the ligand is based on 2288 cases. The success
rate for this step is about 44% overall and is 52% for ‘good’
ligands. As can be seen from Fig. 3, successful site identiﬁca-
tion can be expected for ligands with an RSMCC of well above
0.5 and successful ligand construction for ligands with an
RSMCC of above 0.7. The sections below present an elaborate
discussion on the various factors that affect both steps in the
ligand-building procedure in ARP/wARP.
3.3. Dependence on the ligand size
The location of the binding site and the construction of the
ligand molecule are differently affected by the size of the
ligand (Fig. 6). Consistently with the intrinsic structure of the
algorithm, it is easier to locate the binding sites for larger
ligands, while smaller ligands are simpler to build. One reason
for this is the fact that the site identiﬁcation considers all
possible clusters in the density by their volume. Conversely,
the construction step takes into account all interpretations of a
single selected cluster in terms of a ligand molecule.
The success of identifying the location of a ligand does not
merely depend on ligand size alone. A
major underlying factor is how the
correct density cluster competes with
other clusters during the process of its
selection. These other clusters may
originate from other ligands, which (if
present) leave their imprint in the
electron density, solvent molecules that
have been removed from the PDB entry
before calculation of the map or noise
arising from a possibly incomplete
model, errors in phases or observed
data, etc.
Small ligands, e.g. glycerol, sulfate or
phosphate, are harder to distinguish
from other features in the difference
density map and only in about 40% of
the cases could their location be
correctly determined. However, once
located, such small ligands could be very
successfully constructed with a high
success rate. Medium-sized ligands (20
or more non-H atoms) have larger
density clusters that almost always
dominate over competing density blobs.
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Figure 3
Distribution of the local map correlation for the test sample of 3369 single
largest fully occupied ligands. Those belonging to a ‘good’ ligand subset
are indicated by a curly bracket. The colour coding indicating ligand-
building results is the same as in Fig. 5.
Figure 4
Examples of density maps with different values of the real-space map correlation coefﬁcient
(RSMCC). The ligand adenosinediphosphate is shown as from the PDB entries 1in7 with an
RSMCC of 93% (a) and 1hw8 with an RSMCC of 69% (b). The maps are contoured at 0.06 e A ˚  3
(blue) and 0.15 e A ˚  3 (brown).This simpliﬁes the task and results in a higher success rate for
the location of their site. However, a ligand molecule always
has ﬂexible parts (e.g. aliphatic chains connecting rigid groups)
that may have poorer electron density. The larger the mole-
cule, the more pronounced this effect is, since more such
ﬂexible parts may be contained in a ligand. Particularly for
large ligands (more than 50 atoms), their location by merely
varying the density threshold may become problematic.
Given the identiﬁed site, the success in the construction of
the ligand per se drops rapidly with increasing ligand size
(Fig. 6). The reason lies in the complexity of the label-
swapping task when N atom labels are to be assigned to M
selected cluster grid nodes. M is on average three times higher
than N and the total number of combinatorial permutations
(the upper bound of the number of possible models in the
absence of stereochemical information) is thus approximated
by (3N)!/(2N)!. An increasing number of ligand atoms leads to
an explosive growth in the number of possibilities for label
assignments: while a ten-atom ligand would require checking
about 10
14 assignments in an exhaustive search, a 20-atom
ligand would require 10
34 checks. Limiting the number of
possibilities via a branch-and-bound approach (Zwart et al.,
2004) reduces the computational complexity to about
3N   3
N; the above quoted numbers of possibilities for ten-
atom and 20-atom ligands then become 10
6 and 10
11, respec-
tively. Although this makes the problem computationally
tractable, the outcome of the iterative graph search very much
depends on the correctness of its early steps. The larger the
partial model built at some iteration, the smaller the prob-
ability that its possibly incorrect label assignments can be put
right by preferring another combinatorial choice. If the ligand
to be constructed exceeds a size of 40 atoms, the accumulated
misassignments in the construction
reduce the success rate considerably.
The dependence of ligand building on
the ligand size is similar for the total test
set and for the subset of ‘good’ ligands.
This seems to reﬂect the fact that the
quality of the density map in the binding
site can vary equally well for ligands of
all sizes. Both small and large ligands
can either be well or poorly bound to
the protein, subject to numerous factors
of chemical and physical origin.
3.4. Dependence on the resolution of
the diffraction data
The effect of the resolution of the
diffraction data used for the reﬁnement
and subsequent construction of the
density maps is shown in Fig. 7. The
resolution barely inﬂuences the success
of the identiﬁcation of the ligand-
binding site. This is to be expected, since
the volume corresponding to the ligand-
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Figure 5
Flowchart and results of automatic ligand building for 2663 entries with ligands that contain more
than six non-H atoms, 706 small ligands with ﬁve or six atoms and 1194 ‘good’ ligands. The sites for
large ligands are easier to locate, but it is more difﬁcult to construct them.
Figure 6
Effect of the size of the ligand on the efﬁciency of the procedure. The total test set is in a darker colour; ‘good’ ligands are in a lighter colour.density cluster remains almost unaffected by series-termina-
tion effects. However, at very high resolution (1.0 A ˚ and
higher) the chances of correct identiﬁcation of the binding site
are lowered. The underlying reason lies in the fact that at such
a resolution the atomic features in the density and the ﬂuc-
tuation of the density height along interatomic bonds are very
strong. For a value of  thres higher than about 1  the ligand
density is almost always broken into several disconnected
small pieces. At a lower threshold the ligand-density cluster is
solid but its volume may be of similar size to the volume of
density clusters that are located elsewhere and originate from
noise, excluded solvent etc. This complicates the search of the
binding site immensely. In addition, owing to the scarceness of
our test set in the resolution range higher than 1.0 A ˚ , these
structures have not been taken into account.
In contrast to site identiﬁcation, the performance of the
ligand construction is affected by the resolution: the lower it is,
the lower the success rate (Fig. 7). This could be seen as a
direct consequence of the atomicity approach to the descrip-
tion of the electron density which is employed at many steps in
ARP/wARP (Lamzin & Wilson, 1993). Lower resolution
smoothens the electron density and the discriminative power
of the density feature reduces dramatically. Moreover, the
shape of the cluster becomes increasingly featureless so that
positional ambiguities in the location of sparse grid points
cannot be effectively resolved and the stereochemical features
used in the ligand-building scoring function become weak. It
could thus be concluded that the power of the presented
ligand-building procedure does not extend much beyond
2.5 A ˚ .
Comparing the dependencies of the total test set and of the
subset of ‘good’ligands does not reveal qualitative differences,
as described above in x3.2. A protein–ligand complex may
display a wide spectrum of diffraction properties and at any
resolution it is equally likely overall to have either well or
poorly ordered ligands.
3.5. Dependence on the atomic displacement parameters
The disorder of the atoms in the ligand molecule can be
estimated by a variety of metrics. We used the average ADP
(‘ligand B factor’) taken from the deposited structures and
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Figure 7
Effect of resolution of the X-ray data on the efﬁciency of the procedure. The total test set is in a darker colour; ‘good’ ligands are in a lighter colour.
Figure 8
Effect of the average ligand atomic displacement parameter on the efﬁciency of the procedure. The total test set is in a darker colour; ‘good’ ligands are
in a lighter colour.observed that its increase negatively affects both the identi-
ﬁcation of the ligand site and the ligand construction (Fig. 8).
Particularly high ligand B factors (above 40 A ˚ 2) bring the
performance below the average for the total set. It is under-
standable that sites with very mobile poorly ordered (and
therefore hardly present) ligands are more problematic to
identify. In such sites the electron-density cluster is spread
much more widely and ﬂatly than for ordered ligands, where it
peaks around atomic positions. As a result, given the same
volume, the correct cluster becomes indistinguishable from
competing density features: other ligands, solvent or noise.
Indeed, the cases of ‘good’ ligands do not show such a sharp
falloff with the increase of the ligand B factor. Concurrently,
these are largely the ligands with higher mean B factor, which
have a poorer real-space map correlation coefﬁcient and did
not qualify for our subset of ‘good’ ligands.
The effect of the ADPs on the actual ligand construction
(Fig. 8) is similar, but has a slightly different reason: the
electron density is smeared over a wider area around the
atoms of a ligand, as is the case on lowering the resolution of
the data. With a ﬂatter density distribution in a cluster and the
reduction of geometric distinctness, during their construction
the scores for correct and incorrect partial models lose a good
part of their mutual contrast.
3.6. Dependence on partial disorder of the ligand
In addition to the mean value of ADPs, we investigated the
effect of partial ligand disorder using the ratio of the standard
deviation of ADPs within the reference ligand over their mean
value as an indicator (D),
D ¼
P
i¼1;N
B2
i  
1
N
P
i¼1;N
Bi
   2 "# 1=2
P
i¼1;N
Bi
:
The dependence on this is displayed in Fig. 9. The site-iden-
tiﬁcation step is essentially unaffected by partially disordered
ligand atoms, except in cases where the value of D is close to
zero (the ﬁrst bin in Fig. 9). Although this may look surprising
at a ﬁrst glance, these largely represent cases where the ligand
ADPs were set to the same value and possibly not fully
reﬁned. This might have been caused by poorly deﬁned elec-
tron density, for example. The other reason is related to the
way the ADPs are reﬁned. Typically, restraints are used to
make the B factors of neighbouring atoms similar. The degree
of similarity is expressed in absolute rather than relative units.
Thus, a model with high mean ADP would have a lower value
of D compared with a model with low ADPs. This may lead to
a poorer description of the ligand binding than in the PDB and
result in lower map correlation coefﬁcients.
In contrast to the identiﬁcation of the site, the ligand
construction considerably suffers from partial disorder. For
both high values of D (reﬂecting real partial disorder) and low
values (effect of restraints or a lack of reﬁnement), the
resolving power of shape features and stereochemical metrics
is reduced.
Building partially ordered ligands is a complex scientiﬁc
task and some means of approaching it are discussed in x4.
3.7. Building a ligand that is not the largest
As described above, the building procedure in ARP/wARP
version 6.1 has been designed to build one (the largest) ligand
at a time. Nevertheless, here we brieﬂy overview the results of
a suboptimal use of the software in which the reconstruction
has been attempted on any ligand, regardless of whether a
larger ligand might have been present. The analysis is limited
to the site-identiﬁcation stage.
Based on the design of the procedure, when a mixture of
ligand types is present, ligand-binding sites are most success-
fully identiﬁed for the largest ligand type. This behaviour is
captured in Fig. 10. The success of identifying the location of a
ligand is strongly correlated with the ratio Rsize, which we
deﬁne as the ratio of the size of the ligand to be built to the
size of the largest of the remaining ligands bound to the
protein. For values of Rsize that are lower than one, i.e. an
attempt to build a ligand that is not the largest in the structure,
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Figure 9
The dependence on the partial disorder as judged by the ratio of the standard deviation of ligand ADPs to their mean value. The total test set is in a
darker colour; ‘good’ ligands are in a lighter colour.the likelihood of correct site identiﬁcation rapidly approaches
zero. At the same time, in a considerable number of cases the
location is still correctly identiﬁed, particularly when Rsize is
within the range 0.8–1.0. The reason for this probably lies in
the search of the optimal density threshold  thres, where the
cluster for a smaller ligand may survive an increase of the
contour level at nearly the same volume, whereas the density
for a competing larger entity may break into unconnected
pieces. Fig. 10 also shows that even for the search of the largest
ligands, the success rate for the correct identiﬁcation of the
binding site is still dependent on the size contrast between
competing ligands. Given a noisy electron-density map, the
clusters corresponding to similarly sized but different ligands
may become indistinguishable just by their volume.
4. Concluding remarks
An advantage of the ligand-building module in ARP/wARP is
its ease of use via a CCP4i-type graphical user interface
(Potterton et al., 2003) or via the command line where a user
can setup his/her own pipeline for repeated runs or fast
execution of building tasks. In this way, it lends itself to drug-
development and medium-throughput efforts when a list of
compounds are to be screened against the same protein.
The casting of ligand construction into the framework of an
optimization problem and the quasi-exhaustive graph-search
algorithm allow local modelling decisions to be dealt with in a
very efﬁcient and yet general manner while consulting the
result at a more global level, keeping various models in
memory for comparison. The presented approach is proto-
typical in nature owing to its clear distribution of subtasks,
namely site identiﬁcation and ligand construction. The method
resembles what a human would do: identify the site where to
construct the molecule considering all plausible density blobs
and, having done that, construct the model of the ligand
judging from the shape of the density at the chosen location.
In the current implementation, only the volume of the
electron-density clusters is used for selection of the optimal
density threshold and the identiﬁcation of ligand sites. This
leads to problems for multi-ligand cases, very high resolution
data, partial disorder or a high level of noise in the map.
Learning from the obtained results, we envision various ways
in which the ligand-site identiﬁcation may be improved. One is
the use of the ligand’s density-shape information, i.e. how well
the experimental density matches stereochemical expecta-
tions. Knowledge of the host protein can be exploited to
discriminate binding scenarios at several plausible binding
sites taking the chemical (hydrogen-bonding) environment
into account. Possibly, a number of top-ranked cluster candi-
dates could be tried for a fast ligand construction and the ﬁnal
choice made upon the values of the obtained RSMCC. High
resolution is ideal for ligand construction since the density
height becomes the dominant feature in the scoring. However,
performance currently breaks down with data to a resolution
lower than about 2.5 A ˚ owing to the lack of atomicity. The use
of a sparse cluster representation simpliﬁes the general
problem of the combinatorial tractability of the graph-search
technique. However, the sparsing should still provide a sufﬁ-
ciently good parameterization of the density and accurate
enough seed points for ligand construction; these also depend
on the atomic features of the map. The basic idea of label
swapping may be extended to incorporate all map grid points
within a selected density cluster as well as other parameters of
importance, including the presence of rigid groups and
preferred conformations. Thus, a more sophisticated use of
prior information may prove helpful, especially in providing
better likelihood targets for the construction step.
An issue which is not at all taken into account by the ligand-
building module in ARP/wARP version 6.1 is partial occu-
pancy and particularly high local disorder of the ligand to be
built. In the analysed PDB set we skipped almost 10% of
ligand-building tasks in which the ligand was explicitly
modelled with partial occupancy. This was also the reason to
separate, on the basis of the values of the real-space correla-
tion coefﬁcient, and consider separately 70% of the tasks as
‘good’ ligand cases. Partial occupancy or a complete absence
of a part of the ligand directly affects the shape of the density
cluster. If, despite this difﬁculty, a density cluster is somehow
selected correctly (or already known), it may still not have the
correct shape.
The ligand-building procedure evaluated in this paper is a
sequence of successive steps and is therefore reminiscent of a
software pipeline. Its efﬁciency is thus mostly affected by the
weakest element in the chain. For example, while larger
ligands are easier to locate but harder to build, the highest
success rate can be observed for ligands within the range 20–
30 atoms. This factor of the chain efﬁciency reappears in the
multi-ligand case when the largest ligand should be built ﬁrst
in order to maximize the overall success rate.
Finally, we note that the aim of this study was to help in
making the ligand-building software more advanced and to
assess its performance on the example of ARP/wARP version
6.1 subject to various working conditions close to the standard
use of the software. Ongoing research will address a number of
shortcomings that were pointed out by the study detailed in
this paper. The main beneﬁt of the presented large-scale test
of the software is to give representative results, where repro-
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Figure 10
Efﬁciency of the identiﬁcation of the binding site in the presence of other
smaller (Rsize > 1) or larger (Rsize < 1) ligands.ducibility in a single instance is provided as a probability
estimated on the safe grounds of a large number of test cases.
Terwilliger et al. (2006) subject the evaluation of their method
to the same paradigm. Valid conclusions as to the efﬁciency of
today’s complex model-building software can only be drawn if
more cases shed further light on every instance of a particular
method.
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